Search
Descriptor English: Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
Descriptor Spanish: Combinación Fosfato de Sitagliptina y Clorhidrato de Metformina
Descriptor combinación medicamentosa de fosfato de sitagliptina y clorhidrato de metformina
Scope note: Preparación farmacéutica de fosfato de sitagliptina y clorhidrato de metformina que se utiliza en el tratamiento de la DIABETES TIPO 2.
Descriptor Portuguese: Combinação Fosfato de Sitagliptina e Cloridrato de Metformina
Descriptor French: Association de phosphate de sitagliptine et de chlorhydrate de metformine
Entry term(s): Janumet
Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
Tree number(s): D02.078.370.141.450.500
D03.383.129.799.725.500
D03.383.679.875.500
D26.310.750
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068899
Scope note: A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Public MeSH Note: 2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015
History Note: 2016 (2008)
DeCS ID: 55878
Unique ID: D000068899
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/31
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination - Preferred
Concept UI M000604087
Scope note A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
Preferred term Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
Entry term(s) Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
Janumet - Narrower
Concept UI M0527089
Preferred term Janumet



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey